Related Experiment Videos
Cardiac pacing device therapy for atrial dysrhythmias: how does it work?
1Cardiac Sciences and Cardiac Pacing Program, Grey Nuns Hospital, Edmonton, Canada. mirwin@cha.ab.ca
AACN Clinical Issues
|October 12, 2004
Summary
Atrial fibrillation (AF) management is complex, especially for persistent cases. Pacing strategies show promise for reducing AF episodes and healthcare costs in select patients.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Device Therapy
Background:
- Atrial fibrillation (AF) is a prevalent dysrhythmia with increasing incidence, posing significant clinical and economic challenges.
- Current guidelines require elucidation regarding cardiac pacing device therapy for atrial dysrhythmia control.
- Choosing appropriate pacing systems for symptomatic AF patients presents a complex clinical dilemma.
Purpose of the Study:
- To explore the role of cardiac pacing device therapy in managing paroxysmal and persistent atrial fibrillation.
- To evaluate potential mechanisms of rhythmic control attributed to atrial pacing.
- To address the dilemma of maintaining sinus rhythm versus controlling ventricular rate in symptomatic AF.
Main Methods:
- Review of existing guidelines and published studies on cardiac pacing for AF.
- Analysis of pacing algorithms, including single-site, biatrial, and dual-site atrial pacing.
- Examination of studies investigating pacing for primary prevention and management of recurrent atrial dysrhythmia.
Main Results:
- Atrial pacing mechanisms include rate-dependent effects, ectopy reduction, substrate remodeling, and pause prevention.
- Pacing for primary prevention of AF is a novel concept.
- Suppression algorithms may augment atrial pacing in managing paroxysmal AF in patients with sinus node dysfunction and bradyarrhythmia.
Conclusions:
- Cardiac pacing device therapy is an emerging strategy for AF control, particularly for paroxysmal AF.
- Further research and guideline elucidation are needed for optimal use of pacing in AF management.
- Pacing therapies aim to reduce AF symptoms and associated healthcare costs.